Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
R. Louis (Liège, Belgium), P. Chanez (Marseille, France), F. Menzella (Reggio Emilia, Italy), G. Philteos (Saskatchewan, Canada), B. Cosio (Palma de Mallorca, Spain), N. Lugogo (Ann Arbor, United States of America), G. De Luiz (Barcelona, Spain), T. Harrison (Nottingham , United Kingdom), A. Burden (Cambridge, United Kingdom), T. Adlington (Cambridge, United Kingdom), N. Keeling (Gothenburg, Sweden), J. Kwiatek (Wilmington, United States of America), E. Garcia Gil (Barcelona, Spain)
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Louis (Liège, Belgium), P. Chanez (Marseille, France), F. Menzella (Reggio Emilia, Italy), G. Philteos (Saskatchewan, Canada), B. Cosio (Palma de Mallorca, Spain), N. Lugogo (Ann Arbor, United States of America), G. De Luiz (Barcelona, Spain), T. Harrison (Nottingham , United Kingdom), A. Burden (Cambridge, United Kingdom), T. Adlington (Cambridge, United Kingdom), N. Keeling (Gothenburg, Sweden), J. Kwiatek (Wilmington, United States of America), E. Garcia Gil (Barcelona, Spain). Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study. 1114
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: